IP Library › Granted Patent US 9,636,109
Granted Patent B2
US 9,636,109 · App. 12/507,635 · Granted May 2, 2017

Biologically active sutures for regenerative medicine

Inventors: William L. Murphy (Madison, WI); Jae Sung Lee (Madison, WI); Mark D. Markel (Middleton, WI); Ben K. Graf (Madison, WI); Geoffrey Baer (Madison, WI); Yan Lu (Fitchburg, WI)
Assignee: Wisconsin Alumni Research Foundation
A61B17/06166A61L17/005A61L17/06A61L17/145A61L27/32A61L27/54A61L27/58A61L29/106A61L29/148A61L29/16A61L31/086A61L31/148A61L31/16A61B2017/00889A61B2017/00893
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,636,109
App. No.
12/507,635
Granted
May 2, 2017
Kind
B2
Abstract

The present disclosure generally relates to biodegradable and bioresorbable materials having a mineral layer on the surface of the material. More particularly, the disclosure relates to biodegradable and bioresorbable orthopedic devices having a degradable mineral layer on the surface thereof that can be used as a delivery vehicle for biological substances. Also provided are various methods of using the mineralized devices in tissue regeneration, including bone tissue engineering, and methods for producing the mineralized devices.

Claims (13)

1. A biologically active suture comprising:

a suture material comprising one or more filaments, wherein a surface of the suture material is chemically hydrolyzed and comprises heterogeneous mineral nucleation sites thereon;

at least one degradable mineral layer associated with the surface of the suture material; and

at least one biological substance associated with the degradable mineral layer.

2. The suture of claim 1 wherein the suture material is bioresorbable.

3. The suture of claim 1 wherein the degradable mineral layer comprises a mineral selected from the group consisting of hydroxyapatite, α-tricalcium phosphate, β-tricalcium phosphate, amorphous calcium phosphate, dicalcium phosphate, octacalcium phosphate, calcium carbonate, calcium sulfate, and combinations thereof.

4. The suture of claim 1 comprising at least a first biological substance and a second biological substance.

5. The suture of claim 4 wherein the first biological substance and the second biological substance are associated with the same region of the degradable mineral layer.

6. The suture of claim 4 wherein the first biological substance and the second biological substance are associated with different regions of the degradable mineral layer.

7. The suture of claim 6 wherein the different regions are alternating regions.

8. The suture of claim 1 wherein the suture comprises a first degradable mineral layer associated with the surface of the suture material and at least a second degradable mineral layer associated with a surface of the first degradable mineral layer.

9. The suture of claim 8 wherein the at least one biological substance is associated with the first degradable mineral layer, the second degradable mineral layer, or combinations thereof.

10. The suture of claim 8 wherein the second degradable mineral layer is not associated with a biological substance.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2012
From: BAER, GEOFFREY; LEE, JAE SUNG; MARKEL, MARK; GRAF, BEN; LU, YAN; MURPHY, WILLIAM
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 028011/0896 →
CONFIRMATORY LICENSE Recorded Aug 11, 2009
From: UNIVERSITY OF WISCONSIN MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023074/0984 →
Continuity (1)
Related Publication 20110022085A1 · Jan 27, 2011